JN
John Neis
OtherActivePrincipal at Baird Principal Group
51
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for John Neis.
Investment Thesis & Strategy
Baird Principal Group invests in various stages of fintech, marketingtech, and marketplace companies. They likely seek companies with strong growth potential and a clear path to profitability.
Portfolio Companies
Selected investments from their portfolio of 51 companies
E
Euthymics Bioscience
Other · , 0
N
Netsocket
Other · , 0
A
Akebia Therapeutics
Other · , 0
J
Juventas Therapeutics
Other · , 0
P
Promega
Other · , 0
N
Neurovance
Other · , 0
S
SoftSwitching Technologies
Other · , 0
H
Health Scholars
Other · , 0
S
SkySpecs
Other · , 0
D
Delphinus Medical Technologies
Other · , 0
D
Deltanoid Pharmaceuticals
Other · , 0
T
TAI Diagnostics
Other · , 0
Frequently Asked Questions
John Neis focuses on Seed stage investments.